British Lymphoma Pathology Group
We are happy to announce the upcoming BLPG 2022 Hybrid Meeting which is to be hosted at the Royal College of Pathologists in London on the 24th and 25th November 2022.
This meeting is approved for 11 RCPath CPD points
BLPG 2022
Programme – Day 1
Thursday, 24 November 2022
08:30 – 09:30
Registration
09:30 – 10:25
British Lymphoma Pathology Group (BLPG) Business meeting
10:25 – 10:30
Scientific meeting – introduction and welcome
Prof Stefan Dojcinov, BLPG Chair
10:30 – 11:00
Specialist Integrated Haematological Malignancy Diagnostic Services: Issues and a proposal for a national network
Dr Tom Butler, Laboratory Specialist Interest Group, British Society for Haematology (London, UK)
11:00 – 11:20
Discussion
11:20– 11:40
Coffee break
11:40 - 12:40
International Consensus Classification – B-cell neoplasms
Prof Elias Campo, Barcelona, Spain
12:40 - 13:00
Discussion
13:00 - 14:30
Lunch
14:30 – 15:30
International Consensus Classification – T-cell neoplasms
Prof Leticia Quintanilla-Fend, Tubingen, Germany
15:30 - 15:50
Discussion
15:50 - 16:10
Coffee break
16:10 – 16:40
Lymphoma molecular profiling network – experience of the use of lymphoma NGS panel on the Ion Torrent Genexus platform
Dr Geetha Menon, Liverpool, United Kingdom
Dr Lihui Wang, Liverpool, United Kingdom
Thermo-Fisher sponsored talk
16:40 - 17:00
Discussion
Registration Fees
Please note, this is a “Hybrid” meeting. Registration fees for attendance at the Royal College of Pathologists and online access are the same. Number of places at the RCPath venue is restricted to 40. RCPath CPD approval – 11 points
Online registration before 24th November:
BLPG Members £100
Non-members £125
Students/Trainees £80
On-site registration: £125
Sheba Brick Lane
Meeting Dinner
24th November 2022, 19:30
Sheba Restaurant
136 Brick Lane, London E1 6RU
RESERVE YOUR SEAT BY 18th November
Our Course Sponsor
The world leader in serving scienceTo serve science, Thermo Fisher Scientific needs to stay ahead of it,
we need to anticipate customer needs. We need to constantly think about advancing science, so customers have the freedom to be bolder and more innovative – we are committed to pushing science and technology a step beyond where it is today.